Clinical Trials Directory

Trials / Completed

CompletedNCT01697904

Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns

Randomized Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Preterm infants are born with immature lungs and often require help with breathing shortly after birth. This traditionally involves administering 100% oxygen. Unfortunately, delivery of high oxygen concentrations leads to the production of free radicals that can injure many organ systems. Term and near-term newborns deprived of oxygen during or prior to birth respond as well or better to resuscitation with room air (21% oxygen) compared to 100% oxygen. However, a static concentration of 21% oxygen may be inappropriate for preterm infants with lung disease.Purpose of the study is to investigate if preterm neonates where resuscitation is initiated with 21% fiO2 and adjusted to meet transitional goal saturations (Limited oxygen strategy or LOX) would have less oxidative stress as measured by the oxidative balance ratio of biological antioxidant potential/total hydroperoxide compared to infants where resuscitation is initiated with pure oxygen and titrated for targeted saturations of 85-94% (Traditional oxygen strategy or TOX). Secondary outcomes of interest included need for other delivery room resuscitation measures, respiratory support and ventilation/oxygenation status upon neonatal intensive care unit (NICU) admission, survival to hospital discharge, bronchopulmonary dysplasia and other short-term morbidities.

Conditions

Interventions

TypeNameDescription
PROCEDURETitration of oxygen during newborn resuscitation in delivery room

Timeline

Start date
2010-08-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2012-10-02
Last updated
2012-10-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01697904. Inclusion in this directory is not an endorsement.